Subtype
Malignant Anorectal Neoplasm
CI-CAN-00005864Explore in graph →
452 active trials1 approved drugs6 evidence items
- NCIt
- C215225
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005864Explore in graph →
Clinical trials
1,783 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (174)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05266300 | Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. | completed | — | 722 | University of Southern DenmarkOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT03182179 | Efficacy of Ondansetron in LARS Treatment(Hodolar) | completed | N/A | 48 | Ente Ospedaliero Cantonale, BellinzonaOTHER | 1 | Oct 17, 2022 |
| NCT02489422 | Programs To Support You During Chemotherapy(PRO-YOU) | completed | N/A | 44 | Wake Forest University Health SciencesOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT05572151 | Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer | completed | — | 7,694 | The Second Affiliated Hospital of Harbin Medical UniversityOTHER | 0 | Oct 7, 2022 | clinicaltrials |
| NCT05539417 | Snapshot Rectumcarcinoom 2016 | completed | — | 3,107 | Amsterdam UMC, location VUmcOTHER | 0 | Sep 16, 2022 | clinicaltrials |
| NCT04939103 | TRUS-FNA For The Prediction Of pCR After Neoadjuvant Treatment In Rectal Cancer | completed | — | 63 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Sep 1, 2022 | clinicaltrials |
| NCT05496270 | Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer | completed | — | 1,509 | Sun Yat-sen UniversityOTHER | 0 | Aug 11, 2022 | clinicaltrials |
| NCT05493930 | A Lymph Node Metastasis Predictor (LN-MASTER) in Rectal Cancer | completed | — | 6,578 | Peking Union Medical CollegeOTHER | 0 | Aug 9, 2022 | clinicaltrials |
| NCT02602327 | Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases | completed | Phase 1 | 21 | University of California, San FranciscoOTHER | 1 | Aug 1, 2022 | clinicaltrials |
| NCT05476341 | A Phase I Clinical Trial of Bevacizumab Injection | completed | Phase 1 | 98 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jul 27, 2022 | clinicaltrials |
| NCT01648894 | Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer(GRECCAR6) | completed | Phase 3 | 265 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT02130427 | A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy | completed | N/A | 74 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 22, 2022 | clinicaltrials |
| NCT02569645 | Rosuvastatin in the Treatment of Rectal Cancer | completed | Phase 2 | 45 | AHS Cancer Control AlbertaOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT03039595 | Ploidy and Stroma in Early Rectal Cancer | completed | — | 150 | Oxford University Hospitals NHS TrustOTHER | 1 | Jun 9, 2022 | clinicaltrials |
| NCT05398822 | The Role of TextRAd on Detection of Liver Metastasis in Rectal Cancer | completed | — | 113 | East Suffolk and North Essex NHS Foundation TrustOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT02935309 | Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma | completed | Phase 1 | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT03082495 | Exercise During and After Neoadjuvant Rectal Cancer Treatment(EXERT) | completed | N/A | 36 | University of AlbertaOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT04160650 | Educational Nursing Intervention Among Patients With Colorectal Cancer During Chemotherapy | completed | N/A | 82 | University of TurkuOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT05388513 | Evaluating Factors Affecting Survival in Colon and Rectum Cancer | completed | — | 161 | Umraniye Education and Research HospitalOTHER_GOV | 0 | May 24, 2022 | clinicaltrials |
| NCT04443985 | A Cohort of Predictive Factor of Pathologic Complete Response After Preoperative Neoadjuvant in Rectum Cancer | completed | — | 140 | Mahidol UniversityOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT05381324 | Fistula-associated Anal Adenocarcinoma | completed | — | 1,004 | Medical University of ViennaOTHER | 0 | May 19, 2022 | clinicaltrials |
| NCT02402842 | Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma(Epitopes-HPV02) | completed | Phase 2 | 70 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | May 16, 2022 | clinicaltrials |
| NCT00622557 | General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)(SOCRATES) | completed | — | 200,000 | University Hospitals Cleveland Medical CenterOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT01113736 | Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy(AlloMem) | completed | Phase 1 | 10 | University Hospitals Cleveland Medical CenterOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT03666442 | Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal Cancer | completed | Phase 2 | 61 | West China HospitalOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT04316078 | A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies | completed | N/A | 126 | Sheba Medical CenterOTHER_GOV | 1 | Apr 28, 2022 | clinicaltrials |
| NCT01904656 | CBPR Strategies to Increase Colorectal Cancer Screening in Ohio Appalachia | completed | N/A | 4,509 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT05339763 | Long Term Bowel Function Following Rectal Cancer Surgery | completed | N/A | 171 | Mansoura UniversityOTHER | 1 | Apr 21, 2022 | clinicaltrials |
| NCT03102047 | Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer | completed | Phase 2 | 45 | NSABP Foundation IncNETWORK | 1 | Apr 20, 2022 | clinicaltrials |
| NCT03598231 | Effectiveness of Sacral Neuromodulation in Low Anterior Resection Syndrome(SANLARS) | completed | N/A | 45 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Mar 25, 2022 | clinicaltrials |
| NCT03000374 | Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery(PIER) | completed | Phase 2 | 34 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Mar 17, 2022 | clinicaltrials |
| NCT03931980 | Robotic Versus Laparoscopic Approach for Rectal Cancer Surgery | completed | N/A | 100 | Binh Dan HospitalOTHER | 1 | Mar 14, 2022 | clinicaltrials |
| NCT05274945 | Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer | completed | Phase 2 | 58 | Alexandria UniversityOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT03688906 | AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test | completed | — | 3,275 | Freenome Holdings Inc.INDUSTRY | 2 | Mar 2, 2022 | clinicaltrials |
| NCT00308516 | 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer | completed | Phase 2 | 66 | SCRI Development Innovations, LLCOTHER | 1 | Dec 10, 2021 | clinicaltrials |
| NCT04920435 | Prediction of the Response to Neoadjuvant Radiation Chemotherapy Through Texture Analysis Derived From Medical Imaging(RECTOMICS) | completed | — | 124 | University Hospital, BrestOTHER | 1 | Dec 7, 2021 | clinicaltrials |
| NCT01308190 | Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer | completed | Phase 3 | 173 | Corporacion Parc TauliOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT02550769 | Study of NOTES-TME Versus L-LAR in Rectal Cancer(NOTESvsL-LAR) | completed | N/A | 116 | Corporacion Parc TauliOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT05108753 | Short-term Outcomes of Transanal Total Mesorectal Excision With Structured Training Curriculums in China | completed | — | 175 | Shanghai Minimally Invasive Surgery CenterOTHER | 1 | Nov 5, 2021 | clinicaltrials |
| NCT01987726 | Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors | completed | — | 150 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT05078515 | Multicenter Validation of the PREDICT Score | completed | — | 262 | Mansoura UniversityOTHER | 1 | Oct 14, 2021 | clinicaltrials |
| NCT02665026 | Effectiveness and Safety Study on Different Timing of Preventive Ileostomy Closure After Surgery for Rectal Cancer | completed | N/A | 250 | Huashan HospitalOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT01458509 | Feasibility and Psychometric Properties of Paper vs. Web vs. Automated Telephone Administration of Patient Reported Outcome Surveys | completed | — | 325 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT03107650 | Preoperative Prediction Model of Pathological Outcomes (Mesorectum Quality and Positive Circumferential Resection Margin) in Patients With Mid-low Rectal Cancer(PREMARE) | completed | — | 323 | Pere Planellas GinéOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02981862 | CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas(CaptHPV) | completed | N/A | 100 | Institut de Cancérologie de LorraineOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT00040599 | Safety Study of 90Y-hMN14 to Treat Colorectal Cancer | completed | Phase 1 / Phase 2 | 72 | Gilead SciencesINDUSTRY | 5 | Aug 19, 2021 | clinicaltrials |
| NCT00041652 | Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer | completed | Phase 1 / Phase 2 | 30 | Gilead SciencesINDUSTRY | 1 | Aug 19, 2021 | clinicaltrials |
| NCT01927497 | Biological Mesh Closure of the Pelvic Floor After Extralevator Abdomino Perineal Resection for Rectal Cancer(BIOPEX) | completed | Phase 3 | 104 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT02860234 | Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment | completed | — | 68 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jul 23, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Nov 1, 2022source: clinicaltrials